Physician profile
David Kim
NPI 1194818914
$1,606.14
in general payments reported to CMS, 2019-2025
17 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $102 · 2021: $137 · 2022: $144 · 2023: $106 · 2024: $248 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $636.00 | 2019-2021 | |
| Abbott Laboratories | $199.05 | 2022-2024 | Jot Dx, Gallant |
| Organon LLC | $154.05 | 2022-2025 | |
| Stryker Corporation | $144.29 | 2025 | Surgicount |
| Sun Pharmaceutical Industries INC. | $101.34 | 2020-2021 | |
| Therapeuticsmd, INC. | $72.70 | 2019-2022 | |
| Pfizer INC. | $51.01 | 2024 | |
| Hologic Sales and Service, LLC | $38.17 | 2021 | |
| Davol INC. | $36.70 | 2025 | Arista |
| Boston Scientific Corporation | $33.54 | 2023-2025 | General - Biliary Devices, Lux-Dx Insertable Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $25.00 | 2021 | |
| Scynexis, INC. | $24.60 | 2022 | |
| Vertical Pharmaceuticals, LLC | $22.33 | 2019 | |
| Myovant Sciences INC. | $20.51 | 2022 | |
| Becton, Dickinson and Company | $17.55 | 2023 | Bd Max System, Bd Max Instrument |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $17.15 | 2023 | Ethicon |
| Allergan, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.